Shares of Aurora Cannabis Inc (OTCMKTS:ACBFF - Get Free Report) were down 12.8% during mid-day trading on Monday . The company traded as low as $4.05 and last traded at $4.08. Approximately 4,811,960 shares were traded during trading, an increase of 14% from the average daily volume of 4,224,181 shares. The stock had previously closed at $4.68.
Aurora Cannabis Stock Performance
The company has a 50 day moving average price of $5.05 and a 200 day moving average price of $4.75. The company has a market capitalization of $3.92 billion and a price-to-earnings ratio of 34.00.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
